Description
Curcumin's effects in type 2 diabetes clinical trials are presented, showing its potential to modulate glycemic control and reduce inflammatory markers associated with metabolic dysfunction.
Cite This Figure
![Figure 3: Curcumin's effects in type 2 diabetes clinical trials are presented, showing its potential to modulate glycemic control and reduce inflammatory markers associated with metabolic dysfunction.]() > Source: Melissa Yang et al. "Curcumin in Autoimmune and Rheumatic Diseases.." *Nutrients*, 2019. PMID: [31052496](https://pubmed.ncbi.nlm.nih.gov/31052496/)
<figure> <img src="" alt="Curcumin's effects in type 2 diabetes clinical trials are presented, showing its potential to modulate glycemic control and reduce inflammatory markers associated with metabolic dysfunction." /> <figcaption>Figure 3. Curcumin's effects in type 2 diabetes clinical trials are presented, showing its potential to modulate glycemic control and reduce inflammatory markers associated with metabolic dysfunction.<br> Source: Melissa Yang et al. "Curcumin in Autoimmune and Rheumatic Diseases.." <em>Nutrients</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31052496/">31052496</a></figcaption> </figure>